Evidence map›Paper›PMID 30662335›Full record

ArticleInternational journal of medical sciences2019

Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature.

Andreas Pircher, Georg Schäfer, Andrea Eigentler, Renate Pichler, Martin Puhr, Eberhard Steiner, Wolfgang Horninger, Eberhard Gunsilius, Helmut Klocker, Isabel Heidegger

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Andreas PircherDepartment of Hematology and Oncology, Internal Medicine V, Medical University Innsbruck, Austria.
Georg SchäferDepartment of Pathology, Medical University Innsbruck, Austria.
Andrea EigentlerDepartment of Urology, Medical University Innsbruck, Austria.
Renate PichlerDepartment of Pathology, Medical University Innsbruck, Austria.
Martin PuhrDepartment of Urology, Medical University Innsbruck, Austria.
Eberhard SteinerDepartment of Urology, Medical University Innsbruck, Austria.
Wolfgang HorningerDepartment of Urology, Medical University Innsbruck, Austria.
Eberhard GunsiliusDepartment of Hematology and Oncology, Internal Medicine V, Medical University Innsbruck, Austria.
Helmut KlockerDepartment of Urology, Medical University Innsbruck, Austria.
Isabel HeideggerDepartment of Urology, Medical University Innsbruck, Austria.
Innsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Prostatic NeoplasmsAgedCell Line, TumorCell ProliferationCell SurvivalHumansIntercellular Signaling Peptides and ProteinsMaleMiddle AgedNeoplasm Recurrence, LocalNeovascularization, PathologicNerve Tissue ProteinsPrognosisReceptors, Cell SurfaceRoundabout ProteinsSlit Homolog 2 ProteinIntercellular Signaling Peptides and ProteinsNerve Tissue ProteinsReceptors, Cell SurfaceROBO4 protein, humanRoundabout ProteinsSlit Homolog 2 Proteincancer aggressivenessProstate cancerRobo 4Slit 2tumor recurrence

Identifiers

PMID30662335
PMCPMC6332478
OpenAlexW2908944713

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.